Find News

Filter articles

Applied Filters

Showing 1 to 10 of 872 results

Womble Bond Dickinson boosts IP arm with patent expert

US29-09-2022Sarah Speight

New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department.

Bio-Techne takes patent dispute to UK

UK27-09-2022Staff Writer

The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.

EMA backs switch to biosimilars

EU22-09-2022Muireann Bolger

Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.

US company secures genetically modified rice ban against Chinese rival

China, US15-09-2022Staff Writer

Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.

Texas court awards $41m to US biotech

Japan, US21-07-2022Staff writer

Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.

Haynes Boone hires top biotech patent lawyer

US19-07-2022Sarah Speight

New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office.

BMS petitions SCOTUS to revive $1.2bn win


BMS unit Juno Therapeutics and the Sloan Kettering Institute for Cancer Research have urged the US Supreme Court to reinstate their $1.2 billion win in a patent clash with Kite Pharma, a subsidiary of Gilead.

Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent

Australia24-05-2022Sarah Speight

The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.

Queen’s speech trails gene-editing innovation bill

UK11-05-2022Alex Baldwin

The UK government will implement the Genetic Technology Bill which promises to “remove unnecessary barriers” inherited from the European Union to bolster gene-editing technology.

L’Oreal’s anti-wrinkle cosmetics infringe, claims GlycoBioSciences

US10-05-2022Legal developmentsAlex Baldwin

Canadian pharmaceutical company GlycoBioSciences has sued cosmetics giant L’Oreal, alleging that the French company’s anti-wrinkle products containing hyaluronic acid infringe two patents.

Showing 1 to 10 of 872 results